AI Market Mood: Stock Dashboard
BLCO
Fundamental
Company: Bausch + Lomb Corp
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -0.86
Insider Own: 89.26%
Shs Outstand: 354.09M
Perf Week: 2.60%
Market Cap: 6.02B
Forward P/E: 21.97
EPS next Y: 0.77
Insider Trans: 0.00%
Shs Float: 38.04M
Perf Month: 8.29%
Enterprise Value: 10.71B
PEG: 1.22
EPS next Q: 0.35
Inst Own: 10.26%
Short Float: 8.58%
Perf Quarter: 14.03%
Income: -305.00M
P/S: 1.21
EPS this Y: -15.77%
Inst Trans: -0.02%
Short Ratio: 6.60
Perf Half Y: 39.26%
Sales: 4.98B
P/B: 0.94
EPS next Y Percentage: 45.76%
ROA: -2.23%
Short Interest: 3.26M
Perf YTD: -5.92%
Book/sh: 18.16
P/C: 18.13
EPS next 5Y: 18.00%
ROE: -4.69%
52W High: 18.99 -10.51%
Perf Year: -6.44%
Cash/sh: 0.94
P/FCF: -
EPS past 3/5Y: - -
ROIC: -2.69%
52W Low: 10.45 62.58%
Perf 3Y: 11.41%
Dividend Est.: -
EV/EBITDA: 18.78
Sales past 3/5Y: 8.36% 4.87%
Gross Margin: 54.02%
Volatility W: 2.51%
Volatility M: 3.42%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 2.15
EPS Y/Y TTM: 17.53%
Oper. Margin: 2.85%
ATR (14): 0.52
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 0.98
Sales Y/Y TTM: 6.23%
Profit Margin: -6.13%
RSI (14): 61.13
Recom: 2.31
Dividend Gr. 3/5Y: - -
Current Ratio: 1.51
EPS Q/Q: -799.12%
SMA20: 5.11%
Beta: 0.61
Target Price: 17.23
Payout: -
Debt/Eq: 0.77
Sales Q/Q: 7.11%
SMA50: 8.49%
Rel Volume: 0.50
Prev Close: 16.99
Employees: 13500
LT Debt/Eq: 0.77
Earnings: Oct 29 BMO
SMA200: 20.44%
Avg Volume: 494.17K
Price: 16.99
IPO: May 06, 2022
Option/Short: Yes / Yes
EPS/Sales Surpr.: 12.85% 0.27%
Trades:
Volume: 201,768
Change: 0.00%
Technical:
Latest News:
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Bausch + Lomb ... very bullish
AMGN BLCO
Summary: Analysts have expressed bullish sentiments on Amgen (AMGN) and Bausch + Lomb Corporation (BLCO) in the Healthcare sector. Wells Fargo analyst maintained a Buy rating on both companies, setting price targets of $320.00 for Amgen and $23.00 for BLCO. The consensus ratings for these stocks suggest potential upsides of 14.1% and 31.5% respectively.
Full article2024-04-24T20:31:52Z